Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Moderna Stock Is Rising Today

TheMotleyFool

0 0

Shares of Moderna (NASDAQ: MRNA) were rising 2.6% higher as of 11:25 a.m. EDT on Tuesday. The gain came after the company announced that the European Medicines Agency authorized a third dose of COVID-19 vaccine Spikevax to severely immunocompromised individuals ages 12 and older.

The modest gain for the vaccine stock today reflects the muted impact that the EMA decision will make for Moderna. Authorizing the third dose for only severely immunocompromised individuals limits the market significantly.

Image source: Getty Images.

Source Fool.com

Like: 0

MRNA

Share